E. van Strijen
发表
P. Nibbering,
P. Hiemstra,
L. A. Duits,
2001,
Biochemical and biophysical research communications.
H. Mattie,
E. van Strijen,
A. Krul,
1990,
The Journal of infectious diseases.
P. Nibbering,
H. Thio,
H. Mattie,
2004,
British journal of clinical pharmacology.
P. Nibbering,
P. Hiemstra,
L. A. Duits,
2003,
FEMS immunology and medical microbiology.
L. Dijkshoorn,
A. Bernards,
P. J. van den Broek,
2009,
Journal of Clinical Microbiology.
H. Mattie,
R. Thomeer,
E. van Strijen,
1993,
British journal of clinical pharmacology.
A. V. van Oosterom,
U. Tjaden,
E. D. de Bruijn,
1983,
Journal of chromatography.
H. Mattie,
E. van Strijen,
A. E. Douwes-Idema,
1997,
Antimicrobial agents and chemotherapy.
H. Mattie,
E. van Strijen,
M. V. van Ogtrop,
1992,
Antimicrobial Agents and Chemotherapy.
R. van Furth,
H. Mattie,
E. van Strijen,
1990,
Antimicrobial Agents and Chemotherapy.
H. Mattie,
C. Verhagen,
E. van Strijen,
1994,
British journal of clinical pharmacology.
S. Džeroski,
D. Kocev,
T. Ottenhoff,
2018,
Nature Communications.
R. van Furth,
H. Mattie,
E. van Strijen,
1992,
Antimicrobial Agents and Chemotherapy.
P. Nibbering,
H. Thio,
H. Mattie,
2004,
BMC pharmacology.
E. D. de Bruijn,
E. van Strijen,
J. Hermans,
1987,
Cancer treatment reports.
H. Mattie,
P. J. van den Broek,
E. van Strijen,
1999,
The Journal of antimicrobial chemotherapy.
P. Rozing,
H. Mattie,
E. van Strijen,
1992,
British journal of clinical pharmacology.
S. Džeroski,
D. Kocev,
T. Ottenhoff,
2018,
Nature Communications.
P. Nibbering,
H. Mattie,
E. van Strijen,
2004,
BMC pharmacology.